Both in Pharmaceuticals
Viking Therapeutics vs Enliven Therapeutics
Over the past year VKTX returned −27.5% and ELVN returned +124.2%; their daily moves had a correlation of 0.23.
VKTX −27.5% ELVN +124.2%Growth of $1, one year, split-adjusted
| Metric | VKTX | ELVN |
|---|---|---|
| Price | $26.09 | $44.83 |
| Market cap | $3.33B | $3.28B |
| Today | −2.76% | +0.45% |
| 1 month | −10.9% | −1.4% |
| 6 months | −16.7% | +7.8% |
| Year to date | −25.8% | +191.1% |
| 1 year | −31.5% | +91.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $709.2M | $895.2M |
| Dividend yield | — | — |
| Volatility (60d) | 86.7% | 40.1% |
| Short % of float | 22.8% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).